SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-017194
Filing Date
2022-06-17
Accepted
2022-06-17 17:22:12
Documents
13
Period of Report
2022-06-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47143
  Complete submission text file 0001493152-22-017194.txt   267115

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ensc-20220617.xsd EX-101.SCH 3778
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ensc-20220617_def.xml EX-101.DEF 26881
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ensc-20220617_lab.xml EX-101.LAB 36943
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ensc-20220617_pre.xml EX-101.PRE 25503
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5478
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 221025121
SIC: 2834 Pharmaceutical Preparations